These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Endometrial cancer in patients with breast carcinoma treated with tamoxifen: report of two cases and the literature overview.
    Author: Sliwińska M, Wojtacki J, Sliwiński W.
    Journal: Med Sci Monit; 2000; 6(2):399-406. PubMed ID: 11208346.
    Abstract:
    Tamoxifen (TAM) is the endocrine treatment of choice in the first-line therapy for all stages of breast cancer, in both pre- and postmenopausal women. Some clinical studies indicated a small but significant increase in the risk of subsequent endometrial carcinoma in breast cancer women who take TAM as an adjuvant therapy. In this study, we present two cases of breast cancer patients in whom endometrial cancer was diagnosed during TAM treatment; the current status of knowledge on the relationship between TAM use and the risk of endometrial cancer is reviewed.
    [Abstract] [Full Text] [Related] [New Search]